Intrinsic value of Clorox - CLX

Previous Close

$149.43

  Intrinsic Value

$79.72

stock screener

  Rating & Target

sell

-47%

Previous close

$149.43

 
Intrinsic value

$79.72

 
Up/down potential

-47%

 
Rating

sell

We calculate the intrinsic value of CLX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 19.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.70
  2.93
  3.14
  3.32
  3.49
  3.64
  3.78
  3.90
  4.01
  4.11
  4.20
  4.28
  4.35
  4.42
  4.47
  4.53
  4.57
  4.62
  4.65
  4.69
  4.72
  4.75
  4.77
  4.80
  4.82
  4.83
  4.85
  4.87
  4.88
  4.89
Revenue, $m
  6,134
  6,314
  6,512
  6,728
  6,963
  7,217
  7,490
  7,782
  8,094
  8,426
  8,780
  9,156
  9,554
  9,976
  10,422
  10,894
  11,392
  11,918
  12,473
  13,058
  13,674
  14,323
  15,007
  15,727
  16,484
  17,281
  18,120
  19,001
  19,929
  20,904
Variable operating expenses, $m
  4,681
  4,813
  4,958
  5,116
  5,288
  5,474
  5,673
  5,887
  6,116
  6,359
  6,426
  6,701
  6,992
  7,301
  7,628
  7,973
  8,338
  8,723
  9,129
  9,557
  10,008
  10,483
  10,984
  11,510
  12,065
  12,648
  13,262
  13,907
  14,586
  15,299
Fixed operating expenses, $m
  300
  307
  314
  321
  328
  335
  342
  350
  358
  365
  374
  382
  390
  399
  407
  416
  426
  435
  445
  454
  464
  475
  485
  496
  507
  518
  529
  541
  553
  565
Total operating expenses, $m
  4,981
  5,120
  5,272
  5,437
  5,616
  5,809
  6,015
  6,237
  6,474
  6,724
  6,800
  7,083
  7,382
  7,700
  8,035
  8,389
  8,764
  9,158
  9,574
  10,011
  10,472
  10,958
  11,469
  12,006
  12,572
  13,166
  13,791
  14,448
  15,139
  15,864
Operating income, $m
  1,152
  1,194
  1,240
  1,291
  1,347
  1,408
  1,474
  1,545
  1,621
  1,702
  1,981
  2,073
  2,171
  2,276
  2,387
  2,504
  2,629
  2,760
  2,900
  3,047
  3,202
  3,366
  3,539
  3,721
  3,913
  4,116
  4,329
  4,554
  4,790
  5,040
EBITDA, $m
  1,455
  1,500
  1,550
  1,605
  1,665
  1,731
  1,801
  1,877
  1,959
  2,046
  2,139
  2,239
  2,344
  2,457
  2,575
  2,702
  2,835
  2,976
  3,125
  3,283
  3,449
  3,625
  3,810
  4,006
  4,212
  4,428
  4,657
  4,898
  5,151
  5,418
Interest expense (income), $m
  78
  119
  124
  131
  138
  146
  155
  164
  174
  184
  196
  208
  221
  234
  249
  264
  281
  298
  316
  335
  355
  377
  399
  423
  448
  474
  501
  530
  561
  593
  627
Earnings before tax, $m
  1,034
  1,070
  1,109
  1,153
  1,201
  1,254
  1,310
  1,371
  1,436
  1,506
  1,773
  1,852
  1,937
  2,027
  2,123
  2,224
  2,331
  2,445
  2,565
  2,691
  2,825
  2,967
  3,116
  3,273
  3,439
  3,614
  3,799
  3,993
  4,197
  4,413
Tax expense, $m
  279
  289
  300
  311
  324
  338
  354
  370
  388
  407
  479
  500
  523
  547
  573
  600
  629
  660
  692
  727
  763
  801
  841
  884
  929
  976
  1,026
  1,078
  1,133
  1,191
Net income, $m
  755
  781
  810
  842
  877
  915
  956
  1,001
  1,048
  1,100
  1,294
  1,352
  1,414
  1,480
  1,549
  1,623
  1,702
  1,785
  1,872
  1,965
  2,063
  2,166
  2,275
  2,390
  2,511
  2,638
  2,773
  2,915
  3,064
  3,221

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  4,697
  4,835
  4,986
  5,152
  5,332
  5,526
  5,735
  5,958
  6,197
  6,452
  6,723
  7,010
  7,315
  7,638
  7,980
  8,341
  8,723
  9,126
  9,550
  9,998
  10,470
  10,967
  11,491
  12,042
  12,622
  13,232
  13,874
  14,549
  15,259
  16,006
Adjusted assets (=assets-cash), $m
  4,697
  4,835
  4,986
  5,152
  5,332
  5,526
  5,735
  5,958
  6,197
  6,452
  6,723
  7,010
  7,315
  7,638
  7,980
  8,341
  8,723
  9,126
  9,550
  9,998
  10,470
  10,967
  11,491
  12,042
  12,622
  13,232
  13,874
  14,549
  15,259
  16,006
Revenue / Adjusted assets
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
  1.306
Average production assets, $m
  1,932
  1,989
  2,051
  2,119
  2,193
  2,273
  2,359
  2,451
  2,550
  2,654
  2,766
  2,884
  3,010
  3,142
  3,283
  3,432
  3,589
  3,754
  3,929
  4,113
  4,307
  4,512
  4,727
  4,954
  5,193
  5,444
  5,708
  5,985
  6,278
  6,585
Working capital, $m
  92
  95
  98
  101
  104
  108
  112
  117
  121
  126
  132
  137
  143
  150
  156
  163
  171
  179
  187
  196
  205
  215
  225
  236
  247
  259
  272
  285
  299
  314
Total debt, $m
  2,302
  2,423
  2,557
  2,703
  2,861
  3,032
  3,216
  3,413
  3,624
  3,848
  4,087
  4,340
  4,609
  4,893
  5,195
  5,513
  5,849
  6,204
  6,578
  6,972
  7,388
  7,826
  8,287
  8,773
  9,284
  9,822
  10,387
  10,982
  11,607
  12,265
Total liabilities, $m
  4,138
  4,259
  4,393
  4,539
  4,697
  4,868
  5,052
  5,249
  5,460
  5,684
  5,923
  6,176
  6,445
  6,729
  7,031
  7,349
  7,685
  8,040
  8,414
  8,808
  9,224
  9,662
  10,123
  10,609
  11,120
  11,658
  12,223
  12,818
  13,443
  14,101
Total equity, $m
  559
  575
  593
  613
  634
  658
  682
  709
  737
  768
  800
  834
  871
  909
  950
  993
  1,038
  1,086
  1,136
  1,190
  1,246
  1,305
  1,367
  1,433
  1,502
  1,575
  1,651
  1,731
  1,816
  1,905
Total liabilities and equity, $m
  4,697
  4,834
  4,986
  5,152
  5,331
  5,526
  5,734
  5,958
  6,197
  6,452
  6,723
  7,010
  7,316
  7,638
  7,981
  8,342
  8,723
  9,126
  9,550
  9,998
  10,470
  10,967
  11,490
  12,042
  12,622
  13,233
  13,874
  14,549
  15,259
  16,006
Debt-to-equity ratio
  4.120
  4.210
  4.310
  4.410
  4.510
  4.610
  4.710
  4.810
  4.910
  5.010
  5.110
  5.200
  5.290
  5.380
  5.470
  5.550
  5.630
  5.710
  5.790
  5.860
  5.930
  6.000
  6.060
  6.120
  6.180
  6.240
  6.290
  6.340
  6.390
  6.440
Adjusted equity ratio
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119
  0.119

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  755
  781
  810
  842
  877
  915
  956
  1,001
  1,048
  1,100
  1,294
  1,352
  1,414
  1,480
  1,549
  1,623
  1,702
  1,785
  1,872
  1,965
  2,063
  2,166
  2,275
  2,390
  2,511
  2,638
  2,773
  2,915
  3,064
  3,221
Depreciation, amort., depletion, $m
  303
  306
  310
  314
  318
  322
  327
  333
  338
  344
  159
  166
  173
  181
  189
  197
  206
  216
  226
  236
  248
  259
  272
  285
  298
  313
  328
  344
  361
  378
Funds from operations, $m
  1,058
  1,087
  1,120
  1,156
  1,195
  1,238
  1,284
  1,333
  1,387
  1,444
  1,453
  1,518
  1,587
  1,660
  1,738
  1,821
  1,908
  2,000
  2,098
  2,201
  2,310
  2,425
  2,546
  2,674
  2,809
  2,951
  3,101
  3,259
  3,425
  3,600
Change in working capital, $m
  2
  3
  3
  3
  4
  4
  4
  4
  5
  5
  5
  6
  6
  6
  7
  7
  7
  8
  8
  9
  9
  10
  10
  11
  11
  12
  13
  13
  14
  15
Cash from operations, $m
  1,055
  1,084
  1,117
  1,152
  1,191
  1,234
  1,280
  1,329
  1,382
  1,439
  1,448
  1,512
  1,581
  1,654
  1,731
  1,814
  1,900
  1,992
  2,090
  2,192
  2,301
  2,415
  2,536
  2,663
  2,798
  2,939
  3,088
  3,246
  3,411
  3,585
Maintenance CAPEX, $m
  -108
  -111
  -114
  -118
  -122
  -126
  -131
  -136
  -141
  -147
  -153
  -159
  -166
  -173
  -181
  -189
  -197
  -206
  -216
  -226
  -236
  -248
  -259
  -272
  -285
  -298
  -313
  -328
  -344
  -361
New CAPEX, $m
  -51
  -57
  -62
  -68
  -74
  -80
  -86
  -92
  -98
  -105
  -111
  -118
  -125
  -133
  -141
  -149
  -157
  -166
  -175
  -184
  -194
  -205
  -215
  -227
  -239
  -251
  -264
  -278
  -292
  -307
Cash from investing activities, $m
  -159
  -168
  -176
  -186
  -196
  -206
  -217
  -228
  -239
  -252
  -264
  -277
  -291
  -306
  -322
  -338
  -354
  -372
  -391
  -410
  -430
  -453
  -474
  -499
  -524
  -549
  -577
  -606
  -636
  -668
Free cash flow, $m
  896
  917
  940
  966
  996
  1,028
  1,063
  1,102
  1,143
  1,188
  1,184
  1,235
  1,290
  1,348
  1,410
  1,476
  1,546
  1,620
  1,699
  1,782
  1,870
  1,963
  2,061
  2,165
  2,274
  2,390
  2,512
  2,640
  2,775
  2,917
Issuance/(repayment) of debt, $m
  107
  121
  134
  146
  158
  171
  184
  197
  210
  224
  239
  253
  269
  285
  301
  318
  336
  355
  374
  395
  416
  438
  461
  486
  511
  538
  566
  595
  625
  658
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  107
  121
  134
  146
  158
  171
  184
  197
  210
  224
  239
  253
  269
  285
  301
  318
  336
  355
  374
  395
  416
  438
  461
  486
  511
  538
  566
  595
  625
  658
Total cash flow (excl. dividends), $m
  1,003
  1,038
  1,074
  1,112
  1,154
  1,199
  1,247
  1,299
  1,353
  1,412
  1,422
  1,488
  1,558
  1,633
  1,711
  1,794
  1,882
  1,975
  2,073
  2,177
  2,286
  2,401
  2,523
  2,651
  2,785
  2,927
  3,077
  3,235
  3,400
  3,575
Retained Cash Flow (-), $m
  -17
  -16
  -18
  -20
  -21
  -23
  -25
  -27
  -28
  -30
  -32
  -34
  -36
  -38
  -41
  -43
  -45
  -48
  -51
  -53
  -56
  -59
  -62
  -66
  -69
  -73
  -76
  -80
  -84
  -89
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  986
  1,021
  1,056
  1,093
  1,133
  1,176
  1,222
  1,272
  1,325
  1,382
  1,390
  1,454
  1,522
  1,594
  1,671
  1,751
  1,837
  1,927
  2,023
  2,124
  2,230
  2,342
  2,460
  2,585
  2,716
  2,855
  3,001
  3,154
  3,316
  3,486
Discount rate, %
  6.60
  6.93
  7.28
  7.64
  8.02
  8.42
  8.84
  9.29
  9.75
  10.24
  10.75
  11.29
  11.85
  12.45
  13.07
  13.72
  14.41
  15.13
  15.88
  16.68
  17.51
  18.39
  19.31
  20.27
  21.29
  22.35
  23.47
  24.64
  25.87
  27.17
PV of cash for distribution, $m
  925
  893
  855
  814
  770
  724
  675
  625
  574
  521
  452
  403
  355
  309
  265
  224
  186
  153
  123
  97
  75
  57
  42
  31
  22
  15
  10
  7
  4
  3
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International. Its Cleaning segment consists of laundry, home care and professional products marketed and sold in the United States. Its Household segment consists of charcoal, cat litter and plastic bags, wraps and container products marketed and sold in the United States. Its Lifestyle segment consists of food products, water-filtration systems and filters, and natural personal care products marketed and sold in the United States. Its International segment consists of products sold outside the United States. It markets some of the consumer brand names, such as namesake bleach and cleaning products, Pine-Sol cleaners, Liquid-Plumr clog removers and Kingsford charcoal.

FINANCIAL RATIOS  of  Clorox (CLX)

Valuation Ratios
P/E Ratio 27.5
Price to Sales 3.2
Price to Book 35.6
Price to Tangible Book
Price to Cash Flow 22.2
Price to Free Cash Flow 30.3
Growth Rates
Sales Growth Rate 3.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 34.3%
Cap. Spend. - 3 Yr. Gr. Rate 10.9%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity 256.6%
Total Debt to Equity 405%
Interest Coverage 14
Management Effectiveness
Return On Assets 16.6%
Ret/ On Assets - 3 Yr. Avg. 16%
Return On Total Capital 26.2%
Ret/ On T. Cap. - 3 Yr. Avg. 25.6%
Return On Equity 167.1%
Return On Equity - 3 Yr. Avg. 302%
Asset Turnover 1.3
Profitability Ratios
Gross Margin 44.7%
Gross Margin - 3 Yr. Avg. 44.5%
EBITDA Margin 21.3%
EBITDA Margin - 3 Yr. Avg. 21.2%
Operating Margin 17.3%
Oper. Margin - 3 Yr. Avg. 16.9%
Pre-Tax Margin 17.3%
Pre-Tax Margin - 3 Yr. Avg. 16.9%
Net Profit Margin 11.7%
Net Profit Margin - 3 Yr. Avg. 11.1%
Effective Tax Rate 31.9%
Eff/ Tax Rate - 3 Yr. Avg. 33.4%
Payout Ratio 58.8%

CLX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CLX stock intrinsic value calculation we used $5973 million for the last fiscal year's total revenue generated by Clorox. The default revenue input number comes from 0001 income statement of Clorox. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CLX stock valuation model: a) initial revenue growth rate of 2.7% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.6%, whose default value for CLX is calculated based on our internal credit rating of Clorox, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Clorox.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CLX stock the variable cost ratio is equal to 76.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $294 million in the base year in the intrinsic value calculation for CLX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Clorox.

Corporate tax rate of 27% is the nominal tax rate for Clorox. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CLX stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CLX are equal to 31.5%.

Life of production assets of 17.4 years is the average useful life of capital assets used in Clorox operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CLX is equal to 1.5%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $542 million for Clorox - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 128.086 million for Clorox is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Clorox at the current share price and the inputted number of shares is $19.1 billion.

RELATED COMPANIES Price Int.Val. Rating
OBCI Ocean Bio-Chem 3.99 3.37  hold
CHD Church&Dwight 58.51 61.66  hold
PG Procter&Gamble 81.86 86.63  hold
WDFC WD-40 157.95 88.46  sell
CL Colgate-Palmol 63.55 35.42  sell

COMPANY NEWS

▶ Clorox Is Giving Me Mixed Signals   [Oct-16-18 03:29PM  TheStreet.com]
▶ Cramer's No. 1 fear in this market   [06:41PM  CNBC Videos]
▶ Global oil supply hits 100 barrels per day   [Oct-12-18 01:26PM  Yahoo Finance Video]
▶ Cramer's consumer staples 'power ranking'   [Oct-09-18 07:03PM  CNBC Videos]
▶ Clorox Releases 2018 Integrated Annual Report   [Oct-02-18 06:30AM  PR Newswire]
▶ The Clorox Company (NYSE:CLX): Earnings To Drop Next Year   [Sep-20-18 07:40AM  Simply Wall St.]
▶ Clorox Adding Detailed Ingredients To Labels   [Sep-06-18 10:13AM  Bloomberg]
▶ Clorox CEO: Here's How We Cleaned Up This Quarter   [Aug-08-18 07:27AM  TheStreet.com]
▶ Clorox's Longer-Term Prospects Look Brighter   [Aug-03-18 08:56AM  TheStreet.com]
▶ Clorox: Fiscal 4Q Earnings Snapshot   [06:47AM  Associated Press]
▶ Clorox Q4 Earnings Outlook   [Aug-01-18 03:20PM  Benzinga]
▶ Smucker to close San Francisco office, lay off as many as 100   [Jul-30-18 05:27PM  American City Business Journals]
▶ After-hours buzz: T, MCD and more   [Jul-12-18 06:08PM  CNBC]
▶ 7 Stocks That Can Lead The Market Longterm   [Jul-06-18 12:48PM  Investopedia]
▶ Popcorn maker Pop Gourmet is positioning itself for a sale with Clorox deal   [Jun-21-18 05:00PM  American City Business Journals]
▶ 10 Consumer Stocks on the Clearance Rack   [03:06PM  InvestorPlace]
▶ Clorox vice president of R&D found support helped him come out at work (Video)   [Jun-14-18 02:24PM  American City Business Journals]
▶ 5 Consumer Staples Stocks to Buy for Long-Term Gains   [Jun-13-18 02:15PM  InvestorPlace]
▶ 6 Ways to Beat Rising Interest Rates   [Jun-12-18 02:27PM  Kiplinger]
▶ Best Dividend Paying Stock in June   [09:02AM  Simply Wall St.]
▶ Top technician makes contrarian call on consumer staples   [May-31-18 05:09PM  CNBC Videos]
▶ 3 Reasons to Avoid General Electric Company Stock   [May-29-18 07:27PM  InvestorPlace]
▶ Clorox sets new $2 billion stock buyback program   [May-24-18 09:09AM  MarketWatch]
▶ Clorox Should Start to Stabilize Here   [May-17-18 09:45AM  TheStreet.com]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.